The Latin America, Middle East and Africa Digital Pathology Market is expected to witness market growth of 7.1% CAGR during the forecast period (2020-2026).
Digital Pathology is also called virtual microscopy that refers to the practice of transforming glass slides into digital slides, which can be viewed, managed, and analyzed on a monitor. Besides, the procedure is technically extensive, it also pictures economical attributes by being precise, efficient, a medium for primary identification of chronic diseases, and a digital ecosystem for data management of produce information and via various nodes.
The digital pathology market is anticipated to be fueled due to the technological developments in digital pathology systems. Few enhancements like computerization, digital imaging, multiple fiber-optic communications, and robotic light microscopy, are likely to boost the market growth. The whole slide imaging technique offers more benefits than the regular light microscopes & that factor will create profitable opportunities for the companies of this market.
The technology of digital pathology helps in enhancing the efficiency of labs by decreasing costs, reducing turnaround times, and offering patients access to expertise. Enhancements in lab efficiency are important as patients & physicians rely on lab test results for further diagnostic decisions, and diagnostic tests are necessary to be completed and studied faster and precisely. In addition, granted access to digital slides through web services removes shipping costs and pathologists’ traveling time.
The COVID-19 pandemic has resulted in the imposition of social distancing rules & lockdowns. These kinds of restriction have resulted in the increasing demand for digital pathology solutions because it helps pathologists to distantly evaluate diagnostic results for primary diagnosis. There are many pathologists who are adopting the solutions to get a competitive edge and provide quick services.
Based on Product, the market is segmented into Device, Software and Storage System. Based on End Use, the market is segmented into Hospitals, Diagnostic Labs, Biotech & pharma companies and Academic & research institutes. Based on Application, the market is segmented into Drug Discovery & Development, Disease Diagnosis and Academic research. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Hospitals market dominated the Saudi Arabia Digital Pathology Market by End-use in 2019, thereby, achieving a market value of $6 Million by 2026. The Diagnostic Labs market is experiencing a CAGR of 7.4% during (2020 - 2026). Additionally, The Biotech & pharma companies market is expected to showcase highest CAGR of 7.8% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.
Scope of the Study
Market Segments covered in the Report:
By Product
By End Use
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Digital Pathology is also called virtual microscopy that refers to the practice of transforming glass slides into digital slides, which can be viewed, managed, and analyzed on a monitor. Besides, the procedure is technically extensive, it also pictures economical attributes by being precise, efficient, a medium for primary identification of chronic diseases, and a digital ecosystem for data management of produce information and via various nodes.
The digital pathology market is anticipated to be fueled due to the technological developments in digital pathology systems. Few enhancements like computerization, digital imaging, multiple fiber-optic communications, and robotic light microscopy, are likely to boost the market growth. The whole slide imaging technique offers more benefits than the regular light microscopes & that factor will create profitable opportunities for the companies of this market.
The technology of digital pathology helps in enhancing the efficiency of labs by decreasing costs, reducing turnaround times, and offering patients access to expertise. Enhancements in lab efficiency are important as patients & physicians rely on lab test results for further diagnostic decisions, and diagnostic tests are necessary to be completed and studied faster and precisely. In addition, granted access to digital slides through web services removes shipping costs and pathologists’ traveling time.
The COVID-19 pandemic has resulted in the imposition of social distancing rules & lockdowns. These kinds of restriction have resulted in the increasing demand for digital pathology solutions because it helps pathologists to distantly evaluate diagnostic results for primary diagnosis. There are many pathologists who are adopting the solutions to get a competitive edge and provide quick services.
Based on Product, the market is segmented into Device, Software and Storage System. Based on End Use, the market is segmented into Hospitals, Diagnostic Labs, Biotech & pharma companies and Academic & research institutes. Based on Application, the market is segmented into Drug Discovery & Development, Disease Diagnosis and Academic research. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Hospitals market dominated the Saudi Arabia Digital Pathology Market by End-use in 2019, thereby, achieving a market value of $6 Million by 2026. The Diagnostic Labs market is experiencing a CAGR of 7.4% during (2020 - 2026). Additionally, The Biotech & pharma companies market is expected to showcase highest CAGR of 7.8% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.
Scope of the Study
Market Segments covered in the Report:
By Product
- Device
- Software
- Storage System
By End Use
- Hospitals
- Diagnostic Labs
- Biotech & pharma companies
- Academic & research institutes
By Application
- Drug Discovery & Development
- Disease Diagnosis
- Academic research
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Danaher Corporation (Leica Biosystems)
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- ContextVision AB
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Visiopharm A/S
- 3DHISTECH Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Digital Pathology Market by Product
Chapter 5. LAMEA Digital Pathology Market by End-use
Chapter 6. LAMEA Digital Pathology Market by Application
Chapter 7. LAMEA Digital Pathology Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Danaher Corporation (Leica Biosystems)
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- ContextVision AB
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Visiopharm A/S
- 3DHISTECH Ltd.
Methodology
LOADING...
